Publications

1. Bradbury A.J., Costall, B. Naylor, RJ. and E.S. Onaivi: 5-Hydroxytryptamine involvement in the locomotor activity suppressant effects of amphetamine in the mouse. Psychopharmacology 93: 457-465, 1987.

2. Costall B., Kelly M.E., Naylor R.J. and Onaivi E.S.: The actions of nicotine and cocaine in a mouse model of anxiety. Pharmacology, biochemistry and Behavior. 33(1): 197-203, 1988.

3. Onaivi E.S. and B.R. Martin: Behavioral effects in the mouse during and following withdrawal from repeated ethanol and nicotine administration. Nida Research Monograph 90. Problems of drug dependence 355, 1988.

4. Costall B., Kelly M.E., Naylor R.J. and E.S. Onaivi: Actions of buspirone in a putative model of anxiety in the mouse. J. Pharm. Pharmacol. 40: 494-500, 1988.

6. Onaivi E.S. and B.R. Martin: A neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety. Prog. Neuro-Psychopharmacol & Biol. Psychiatry, 13: 963-976, 1989.

7. Costall B., Kelly M.E., Naylor R.J. and E.S., and M.B. Tyers: Neuroanatomical sites of action of 5-HT₃ receptor agonist and antagonists for alteration of aversive behavior in the mouse. Br. J. Pharmacol. 96: 325-332, 1989.

8. Onaivi E.S., Todd S. and B.R. Martin: Behavioral effects in the mouse during and following withdrawal from ethanol ingestion and/or nicotine administration. Drug and Alcohol Dependence. 24:205-211, 1989.

9. Martin B.R., Onaivi E.S. and T.J. Martin. What is the nature of mecamylamine's antagonism of the central effects of nicotine. Biochemical Pharmacology, 38(20):3391-3397, 1989.

10. Costall B., Kelly M.E., Onaivi E.S. and Naylor R.J.: The effect of ketotifen in rodent models of anxiety and on the behavioral consequences of withdrawing from treatment with drugs of abuse. Naunyn-Schmiedebergs Archives of Pharmacology, 1990, June, 341(6): 547-551.

11. Singh V.B., Onaivi E.S., Tam-Hao Phan, and Margaret C. Boadle-Biber: The increase in rat cortical and midbrain tryptophan hydroxylase activity in response to acute or repeated sound stress are blocked by bilateral lesions to the central nucleus of the amygdala. Brain Research 530: 49-53, 1990.

12. Costall B., Jones B.J., Kelly M.E., Onaivi E.S., Naylor R.J. and M.B. Tyers: Odansetron inhibits a behavioral consequence of withdrawing from drugs of abuse. Pharmacol. Biochemist and Behav. 1990 June, 36(2): 339-344.

13. Onaivi E.S., Green M.R. and B.R. Martin: Pharmacological characterization of cannabinoids in the Elevated-Plus Maze. J. of Pharmacol. & Exp. Ther., 253(3): 1002-1009., 1990.

14. Costall B., Jones B.J., Kelly M.E., Naylor R.J., Oakley N.R., Onaivi E.S. and M.B. Tyers. The effects of Ondansetron (GR38032F) in rats and mice treated subchronically with diazepam. Pharmacol. Biochem. Behav., 34: 769-778. 1990.

15. Barnes J.M., Costall B., Coughlan J., Domeney A.M., Gerrard P.A., Kelly M.E., Naylor R.J., Onaivi E.S., Tomkins D.M. and M.B. Tyers: The effects of Ondansetron, a 5-HT₃ receptor antagonist, on cognition in rodents and primates. Pharmacology Biochemistry and Behavior, 35:955-962, 1990.

16. Costall B., Jones B.J., Kelly M.E., Onaivi E.S., Naylor R.J., and M.B. Tyers: Sites of action of Odansetron to inhibit withdrawal from drugs of abuse. Pharmacology, Biochemistry and Behavior, 1990 May, 36(1): 97-104.

17. Barnes NM, Costall B., Kelly M.E., Onaivi E.S. and Naylor R.J.: Ketotifen and its analogues reduce aversive responding in the rodent. Pharmacology, biochemistry and Behavior 37(4): 785-793, 1990.

18. Prasad C, Hilton C.W., Szec C, Onaivi E.S. and P. Vo: Could dietary proteins serve as Cyclo His Pro precursors. Neuropetide 19: 17-21, 1991.

19. Onaivi E.S., Talton S, and C. Prasad. The level of protein in diet modulates the behavioral effects of amphetamine. Book Chapter Endocrine and Nutritional Control of Basic Biological Functions, H. Lehnert R. Murison, H. Weiner, D. Hellhammer and J. Beyer (Eds), 1991.

20. Hamdi A., Onaivi E.S. Farooqui S, and C. Prasad. Levels of Protein in diet modulates dopamine receptor. Life Science 50: 1529-1534, 1992.

21. Salonen M, Onaivi E.S., and Maze M. Dexmedetomidine synergism with midazolam in the elevated plus-maze in rats. Psychopharmacology 108: 229-234, 1992.

22. Onaivi E.S., Brock J.W., and C. Prasad. Dietary protein levels alter rat behavior. Nutrition Research. 12: 1025-1039, 1992.

23. Onaivi E.S., Maguire P. Davies F, and Loew G. Comparison of the behavioral and central BDZ binding profile in three rat strains. Pharmacol. Biochem. Behavior 43(3): 825-831 (1992).

24. Akinshola, B. E., Chakrabarti, A. and Onaivi, E. S. In-vitro and in-vivo action of cannabinoids. Neurochemical Research 24(10): 1235-1242, 1999.

25. Akinshola, B. E., Taylor, R. E., Ogunsitan, A. B. and Onaivi, E. S. Anandamide inhibition of recombinant AMPA receptor subunits in xenopus oocytes is increased by forsko lin and 8-bromo-cyclic AMP. Naunyn-Schmiedeberg’s Arch Pharmacol. 360: 242-248, 1999.

26. Hubbard, J. R., Franco, S. E. and Onaivi, E. S. Marijuana: Medical Implications. Am

Fam Physcian 60: 2583-93, 1999.

27. Onaivi, E. S., Ali, S. F and Chakrabarti, A. In-vivo ibogaine blockade and in-vitro PKC action of cocaine. Annals New York Acad. Sci. 844: 227-244, 1998.

28. Onaivi, Emmanuel S., Gautam Chaudhuri, Asli S. Abaci, Monica Parker, Donald H. Manier, Peter R. Martin and John R. Hubbard: Expression of cannabinoid receptors and their gene transcripts in human blood cells. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 23: 1063-1077, 1999.

29. Onaivi, E. S., Reggio, P. H. and Chakrabarti, A. Genes encoding marijuana receptors. NIDA Res. Monog., 178: 238, 1998.

30. Brock, J. W., Farooqui, S. M., Onaivi, E. S., Hamdi, A. and Prasad, C. Dietary protein and central monoamine concentrations in the rat. Nutritional Neuroscience 1: 69-76, 1998.

31. Chakrabarti, A., Ekuta, J. E. and Onaivi, E. S. Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice. Brain Res. Bulletin 45: 67-74, 1998.

32. Stubbs, L., Chittenden, L., Chakrabarti, A and Onaivi E. S. The mouse cannabinoid receptor gene is located in proximal chromosome 4. Mammalian Genome, 7: 165-166, 1996.

33. Onaivi, E. S., Chakrabarti, A and Chaudhuri, G. Cannabinoid receptor genes. Progress in Neurobiology, 48: 275-305, 1996.

34. Onaivi, E. S., Bishop-Robinson, C.,Chakrabarti, A., Motley, E. D and Chirwa, S. S Neurobiological actions of cocaine in the hippocampus. Ann. NY Acad. Sci., 801: 76-94, 1996.

35. Onaivi E.S. Changes in dopamine, DA-D₂ receptor mRNA expression following apomorphine induced hyothermia and Stereotypy. NeuroReport 4, 703-705. 1993.

36. Davies, M. F., Onaivi, E. S., Chen, S. -W., Maguire, P., Tsai, N. F and Loew, G. Evidence for central BDZ receptor heterogeneity from behavior tests. Pharmacol. Biochem. Behav. 49, 47-56, 1994.

37. Prasad C, Ikegami, H., Shimizu, I. and Onaivi, ES. Chronic nicotine intake decelerates aging of nigrostriatal dopaminergic neurons. Life Sciences 54: 1169-1184, 1994.

38. Farooqui, S., Brock, J. W., Onaivi, E. S., Hamdi, A and Chandan Prasad. Differential modulation of dopaminergic systems in the rat brain by dietary protein. Neurochemical Research, 19: 167-176. 1994.

39. Onaivi, E. S., Payne, S., Brock, J. W., Hamdi, A., Farooqui, S. and Prasad. Chronic nicotine reverses age-associated increase in tail-flick latency and anxiety in rats. Life Sciences, 54: 193-202, 1994.

40. Onaivi, E. S., Bishop-Robinson, C., Darmani, N. A. and Sanders-Bush, E. Behavioral effects of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus-maze. Life Sciences, 57: 2455-2466, 1995.

41. Chakrabarti, A., Onaivi, E. S. and Chadhuri, G. Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein. DNA Sequence 5(6): 385-388, 1995.

42. Onaivi, E. S., Chakrabarti, A., Gwebu, E. T. and Chaudhuri, G. Neurobehavioral effects of delta-9-THC and cannabinoid receptor gene expression in mice. Behavioral Brain Research 72(1-2): 115-125, 1995 .

43. Onaivi, E. S., Bishop-Robinson, C.,Chakrabarti, A., Motley, E. D and Chirwa, S. S Neurobiological actions of cocaine in the hippocampus. Ann. NY Acad. Sci., 801: 76-94, 1996.

44. Onaivi, E. S., Chakrabarti, A and Chaudhuri, G. Cannabinoid receptor genes. Progress in Neurobiology, 48: 275-305, 1996.

45. Stubbs, L., Chittenden, L., Chakrabarti, A and Onaivi E. S. The mouse cannabinoid receptor gene is located in proximal chromosome 4. Mammalian Genome, 7: 165-166, 1996.

46. Chakrabarti, A., Ekuta, J. E. and Onaivi, E. S. Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice. Brain Res. Bulletin 45: 67-74, 1998.

47. Brock, J. W., Farooqui, S. M., Onaivi, E. S., Hamdi, A. and Prasad, C. Dietary protein and central monoamine concentrations in the rat. Nutritional Neuroscience 1: 69-76, 1998.

48. Onaivi, E. S., Ali, S. F and Chakrabarti, A. In-vivo ibogaine blockade and in-vitro PKC action of cocaine. Annals New York Acad. Sci. 844: 227-244, 1998.

49. Onaivi, E. S., Reggio, P. H. and Chakrabarti, A. Genes encoding marijuana receptors. NIDA Res. Monog., 178: 238, 1998.

50. Akinshola, B. E., Chakrabarti, A. and Onaivi, E. S. In-vitro and in-vivo action of cannabinoids. Neurochemical Research 24(10): 1235-1242, 1999.

51. Akinshola, B. E., Taylor, R. E., Ogunsitan, A. B. and Onaivi, E. S. Anandamide inhibition of recombinant AMPA receptor subunits in xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP. Naunyn-Schmiedeberg’s Arch Pharmacol. 360: 242-248, 1999.

52. Hubbard, J. R., Franco, S. E. and Onaivi, E. S. Marijuana: Medical Implications. Am Fam Physcian 60: 2583-93, 1999.

53. Onaivi, Emmanuel S., Gautam Chaudhuri, Asli S. Abaci, Monica Parker, Donald H. Manier, Peter R. Martin and John R. Hubbard: Expression of cannabinoid receptors and their gene transcripts in human blood cells. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 23: 1063-1077, 1999.

54. Arinami, T., Ishiguro H. and Onaivi, E. S. Polymorphisms in genes involved in neurotransmission in relation to smoking. Eur J Pharmacol. 410: 215-226, 2000.

55. Zhang, Z. J., Schmidt, D. E., de Paulis, T., Trivedi, B. E., Onaivi, E. S, Ebert, M. H and Hewlett, W. A. Anxiolytic-like effects of DAIZAC, a selective high-affinity 5-HT₃ receptor antagonist, in the mouse elevated plus-maze. Pharmacol. Biochem Behav. 69: 571-578, 2001.

56. Onaivi, E. S., Akinshola, B. E and Ali, S. F. Changes in gene expression and signal transduction following ibogaine treatment. Alkaloids Chem Biol. 56: 135-153, 2001.

57. Onaivi, E. S., Ali, S. F., Chirwa, S. S., Zwiller, J., Thiriet, N., Akinshola, B. E and Ishiguro H. Ibogaine signals addiction genes and methamphetamine alteration of long-term potentiation. Ann N Y Acad Sci 965: 28-46, 2002.

58. Onaivi, E. S., Leonard, C. M., Ishiguro, H., Zhang, P-W., Lin, Z., Akinshola, B. E. Uhl, G. Endocannabinoids and cannabinoid receptor genetics. Prog. Neurobiology 66:307-344, 2002.

59. Onaivi, E. S., Ishiguro, H., Lin, Z., Akinshola, B. E., Zhang, P-W and Uhl, G. R: Cannabinoid receptor genetics and behavior in: Onaivi, E. S (ed.), Biology of marijuana: from gene to behavior. London & New York: Taylor & Francis, 1-44, 2002.

Abstracts

1 Costall B., Naylor R.J. and E.S. Onaivi: A model of asymmetry and circling behavior following asymmetric lesion of mouse medial raphe nucleus. Br. J. Pharmacol. Suppl. 87: 214, 1986.

2 Onaivi E.S.: Receptor changes and neurotransmitter dysfunction in animal models of neurological disorders. European Neuroscience Association Autumn School, Santa Marguerita, Italy, 1987.

3 Onaivi E.S., Kelly M.E. and B. Costall: The topography of brain sites involved with the mediation of anxiolytic activity and anxiogenesis in the rodent. European Neuroscience Association Winter School, Zuoz, 1987.

4 Onaivi E.S., Kelly M.E. and B. Costall: The locus of drug action in the brain to alter anxiety changes associated with chronic nicotine, cocaine and alcohol intake. European Neuroscience Association Winter School, Zouz, 1987.

5 Costall B., Kelly M.E., Naylor R.J., Onaivi E.S. and M.B. Tyers: Topography of the anxiolytic action of 5-HT₃ receptor antagonists in mouse brain. Neurosci. Lett. Supp. 29: 571, 1987.

6 Costall B., Naylor R.J. and E.S. Onaivi: Circling behavior following lesion of the MRN is modified by drug action on 5-HT systems. Br. J. Pharmacol. Supp. 90: 255, 1987.

7 Kelly M.E., Costall B., Domney A.M. and E.S. Onaivi: Changes in anxiety during intake of drugs of addiction and anxiogenesis of abstinence withdrawal in rodent and primate. European Neuroscience Association Winter School, Zuoz, 1987.

8 Costall B., Naylor R.J., Onaivi E.S. and M.B. Tyers: GR38032F antagonizes the aggression caused by medial raphe nucleus lesions in the mouse. Neurosci. Lett. Supp. 29: 570, 1987.

9 Barry J.M., Costall B., Kelly M.E., Naylor R.J. and E.S. Onaivi: A simple habituation test on the mouse. Brit. J. Pharmacol. Suppl. 92: 651, 1987.

10 Costall B., Kelly M.E. and E.S. Onaivi: Reduction in anxiogenesis of withdrawal from long-term alcohol and nicotine intake by diazepam action in the amygdala. Presented at British Ass. Psychopharmacology, Cambridge, July 1987.

11 Onaivi E.S. and B.R. Martin: The effects of some cannabinoids in a model of anxiety in rats and mice. Pharmacologist A135.7, 1988.

12 Onaivi E.S., Rosecrans, J.A. and B.R. Martin: Acute and subacute effects of nicotine in a mouse model of anxiety: Comparison with the reference anxiolytic diazepam. Presented at the International Symposium on Nicotinic Receptors in the CNS, Uppsala, Sweden, June 19-21, 1988.

13 Boadle-Biber M.D., Corley K.C., Onaivi E.S., Phan T.H. and V.B. Singh: Activation of cortical tryptophan hydroxylase by sound stress is blocked by bilateral lesions to the central nucleus of the amygdala. International Symposium on Serotonin from Cell Biology to Pharmacology and Therapeutics. 60, 1989.

14 Onaivi ES, Little PJ and Martin PJ: Approaches to the determination of the central sites of action of cannabinoids. ICSG meeting, Richmond, VA, 1989.

15 Costall B., Kelly M.E., Naylor R.J., Onaivi E.S., and Tyers M.B: Topography of action of GR38032F to inhibit behavioral consequences of withdrawing from treatment with drugs of abuse. International Symposium on Serotonin from Cell Biology to Pharmacology and Therapeutics. 175, 1989.

16 Martin B.R., Onaivi E.S. and M.R. Green: Antagonism of D⁹-THC-induced anxiogenesis in mice. FASEB Journal 3(4): A 1034, 1989.

17 Onaivi E.S., Mitchell J., Green M.R. and B.R. Martin: Predicting drugs with abuse potential using a mouse model of anxiety. FASEB Journal 3(3) A 586 1989.

18 Green M.R., Onaivi E.S., Winckler R.L. and B. R. Martin: The behavioral effects of delta-9-THC in different mouse strains. Virginia Academy of Science 67th Annual meeting May 23-26, 1989.

19 Onaivi E.S Brenda Costall, M.E Kelly and R.J Naylor. Behavioral models for the assessment of drug action on cerebral serotonin function. The New York academy of sciences Abstracts. July 10-13, 92, 1989.

20 Onaivi E.S Brenda Costall, and R.J Naylor. Serotonergic involvement in the classical dopamine mediated stereotypy and catalepsy. Soc. Neurosc. Absts., 15: 235.2, 1989.

21 Barnes J.M. Costall B. Kelly, M.E., Naylor R.J., Onaivi E.S., Tomkins D.M., and Tyers M.B. GR38032F improves performance in a mouse habituation test, and inhibits cholinergic-linked deficits. Brit. J. Pharmacol., 98: 693p. 1989.

22 Onaivi E. S., Brock J.W., Hamdi A. and Prasad C. High-protein diet modulates dopamine- and non-dopamine mediated behaviors in rats. Soc., Neurosc. Absts. 16(2): 433.1, 1990.

23 Onaivi E. S., Talton S. and Prasad C. Level of protein in diet modulates the behavioral effects of amphetamine. The Symposium on Endocrine and Nutritional control of basic biological functions. W. Germany, 1990.

24 Onaivi E. S., Talton S and C Prasad. The behavioral effects of delta-9-THC is potentiated by dietary protein levels. The Clinical Research, Southern meeting, 38(4): 939A.

25 Hamdi A, Onaivi E. S, Farooqui S, and C Prasad. Levels of Protein in diet modulates dopamine receptor. The Faseb Journal, 5(4): A853, 1991.

26 Onaivi E. S., Payne S, Brock J. W, Hamdi A, Farooqui S, and C Prasad. The performance of Sprague-Dawley and Hooded rats in the shuttle box avoidance paradigm is dependent on the level of protein in diet. Third International Brain Research Organization (IBRO) World Congress of Neuroscience Abstracts, Montreal, Canada. P66.36, 1991.

27 Onaivi E. S., Payne S, Brock J. W, Farooqui S, and C Prasad. Nicotine and age-associated decrease in tail-flick latency. Nida Research Monograph 119: 408, 1992.

28 Salonen M, Onaivi ES, and Maze M. Dexmedetomidine synergism with midazolam in the elevated plus-maze in rats. Faseb Journal 5(6): A1880, 1992.

29 Onaivi ES and S Payne. Changes in dopamine, DA-D2 receptor mRNA expression following apomorphine induced hypothermia and stereotypy. Faseb Journal 5(6): A1831, 1992.

30 Brock J. Farooqui S, Onaivi ES, Hamdi A and Prasad C. Dietary Protein modulates dopamine levels in the rat brain. Soc. Neurosc. Absts 18(2): 634.16, 1992.

31 Onaivi ES, Little PJ and Martin BR. Approaches to the determination of the central sites of action of cannabinoids. Soc. Neurosc. Absts 18(1) 157.7, 1992.

32 Hamdi A, Brock JW, Farooqui SM, Onaivi ES and Prasad C. Differential effects on 5-HT levels in the rat brain with changes in dietary protein/carbohydrate ratio. Presented at the clinical Research, Southern meeting in January, 1993.

33 Onaivi ES. The anxiolytic profile of buspirone can be detected in the elevated plus-maze test following a₂-stimulation by dexmedetomidine. Soc. Neurosc. Absts. 19(1):310.8. 19993.

34 Onaivi ES and Chaudhuri, G. Are there subtypes of marijuana receptors in the brain? ACNP meeting Honolulu. 1993.

35 Shockley DC, Ansah TA, Cornish JW and Onaivi ES. Strategies for evaluating drug abuse pharmacotherapy. Nida Research Monograph 141(1): 430, 1994.

36 Chaudhuri, C and Onaivi ES. Characterization of the transcriptional initiation sites of the brain-type and the peripheral-type human cannabinoid receptor genes. J. cellular Biochem. 18C: 16, 1994.

37 Chakrabarti, C Onaivi ES and Chaudhuri C. Structural characterization of cannabinoid receptor genes. NIDA Research Monograph series, 153(II): 401, 1994.

38 Bishop-Robinson, C., Freeman, L., Mock, Y. D., Ford, B. D., Motley, E. D., Parker, K., Chakrabarti, A., Chaudhuri, G., Chirwa, S., Hatcher, F. M. and Onaivi, E. S. The expression of protein kinase C isoforms in PC12 cells are differentially modulated by cocaine and alcohol. NIDA Research Monograph series, 153(II): 301, 1994.

39 Onaivi ES, Chakrabati A and Chaudhuri C. Evolutionary characterization of marijuana receptor genes. Presented at NARCE conference Atlanta, 1994.

40 Onaivi ES, Parker KA, Chakrabarti A, Chaudhuri G, Motley ED, Bishop-Robinson C and Chirwa S. Neurobiology bases of methamphetamine action in the hippocampus. Society for Neuroscience abstracts 20(2) 529.2, 1994.

41 Chakrabarti, A., Onaivi ES and Chaudhuri C. Cloning, sequencing and characterization of mouse brain-type cannabinoid receptor gene. The Faseb Journal, 9(3): 2320, A404, 1995

42 Parker, K. A., Atkins, D., Bishop-Robinson, C., McClendon, K. and Onaivi, E. S. Caffeine alters the performance of three mouse strains in the elevated plus-maze test. The Faseb Journal, 9(3): 2357, A407, 1995.

43 Bishop-Robinson, C., Onaivi, E. S. and Zawia, N. The expression of protein kinase C isoforms in lead exposed PC12 cells following administration of cocaine and alcohol. The Faseb Journal, 9(4): 5462, A941, 1995.

44 Onaivi, E. S., Bishop-Robinson, C., Parker, K., Chakrabarti, A., Chaudhuri, G. and Chirwa, S. S Neurobiology of the action of cocaine in the hippocampus. The Faseb Journal, 9(3): 2320, A401, 1995.

45 C. Bishop-Robinson, E. S. Onaivi, N. A. Darmani and E. Sanders-Bush. Behavioral effects of (±‚-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus-maze test. Society for Neuroscience abstracts 21(2) 298.11, 1995.

46 Atkins, D. S., Zawia, N and Onaivi, E. S. Acrylamide-induced changes in the expression of Protein kinase isozymes in PC12 cells. Society for Neuroscience abstracts 21(2) 538.6, 1995.

47 Chakrabarti, A., Ekuta, J. E., Smith, J. and Onaivi E. S. Neurobehavioral effects of anandamide and cannabinoid receptor gene expression in mice. The Faseb Journal, 10(3): 4111, A711, 1996.

48 Onwere, I., Chakrabarti, A. and Onaivi, E. S. Effect of ibogaine on cocaine withdrawal anxiogenesis in mice. The Faseb Journal, 10(3): 2595, A450, 1996.

49 Onaivi, E. S., Chakrabarti, A., McDuffie, I., Chittenden, L. R., Stubbs, L. and Chaudhuri, G. Genes encoding marijuana receptors and their chromosomal localization. The Faseb Journal, 10(3): 1730, A300, 1996.

50 Onaivi, E. S., Chakrabarti, A., Chittenden, L. R. and L. Stubbs. Neurobehavioral specificity of Genes encoding cannabinoid receptors and their chromosomal localization. Abstracts of the International Behavioral Neuroscience Society, 5: 24, May 1996.

51 Chakrabarti, A., Rossby, S. P., Manier, D. H., Perrin, C., Onaivi E. S. and Sulser, F. Molecular correlates of a chronic mild stress model of depression. Soc. Neurosc. Absts 22(3) 809.15, 1996

52 Onaivi, E. S. and Chakrabarti, A. Neurobehavioral specificity of genes encoding cannabinoid receptors. Soc. Neurosc. Absts 22(3) 662.5, 1996.

53 Onaivi, E. S., Chakrabarti, A and Biaggioni, I. Behavioral and central cardiovascular effects of cocaine. Soc. Neurosc. Absts 23(1) 169.1, 1997.

54 Chakrabarti, A., Onaivi, E. S., Sulser, F. and Akinshola, B. E. Interaction of cannabinoids with NMDA and non-NMDA glutamate receptors. Soc. Neurosc. Absts 23(1) 376.11, 1997.

55 Dutse, C., Schmidt, D. E. and Onaivi, E. S. Aggression and hyperactivity following lesions of the raphe nuclei: Behavioral and neurochemical correlates. Soc. Neurosc. Absts 23(1) 387.7, 1997.

56 Onaivi, E. S., Stubbs, L., Chakrabarti, A., Chittenden, L., Hurst, D.P., Akinshola, B. E., Shire, D. and Reggio, P. H. Murine cannabinoid receptor genetics. The Faseb J. 12(4): A194, 1998.

57 Onaivi, E. S., Chakrabarti, A., Stubbs, L., Chittenden, L., Hurst, D.P., Akinshola, B. E., Shire, D. and Reggio, P. H. Cannabinoid receptor genetics and behavior. ICRS Absts., 28, 1998.

58 Onaivi, E. S., Akinshola, B. E. and Chakrabarti, A. Cannabinoid (CB1) receptor antagonism induces anxiolysis. ICRS Absts., 132, 1998.

59 Onaivi, E. S., Stubbs, L., Chakrabarti, A., Chittenden, L., Hurst, D.P., Akinshola, B. E., Shire, D., Parker M., Hubbard, J. R. and Reggio, P. H. Cannabinoid receptor genetics and Behavior. Soc. Neurosc. Absts., 24(2), 508.1, 1998.

60 Chakrabarti, A., Akinshola, B. E., Ansah, T. A., and Onaivi, E. S. Cannabinoid (CB1) receptor antagonism induces anxiolysis. Soc. Neurosc. Absts., 24(2), 508.1, 1998

61 Chakrabarti, A., Ali, S. F. and Onaivi, E. S. In-vivo Ibogaine blockade and in-vitro PKC action of cocaine. NIDA Res. Monog., 178: 237, 1998.

62 Onaivi, E. S., Stubbs, L., Chakrabarti, A., Chittenden, L., Hurst, D.P., Akinshola, B. E., Shire, D. and Reggio, P. H. Anandamide and murine cannabinoid receptor genetics. NIDA Res. Monog., 179: 237, 1999.

63 Onaivi, E. S. and Akinshola, B. E. In-vitro and in-vivo action of cannabinoids. The Faseb J. 13(5): II 823.2, 1999.

64 Onaivi, E. S., Chaudhuri, G., Abaci, A. A., Parker, M., Manier, D. H., Martin, P. R. and Hubbard, J. R. The influence of gender and ethnicity on the expression of cannabinoid receptors and their gene transcripts. CPDD Absts., 1999.

65 Onaivi, E. S., Chaudhuri, G., Abaci, A. A., Parker, M., Manier, D. H., Martin, P. R. and Hubbard, J. R. Expression of cannabinoid receptors and their gene transcripts in human blood. ICRS Absts. 1999.

66 Akinshola, B. E., Onaivi, E. S. and Taylor, R. E. Effects of N-glycosylated side chains on ethanol sensitivity of recombinant AMPA glutamate receptor. RSA Absts. 1999.

67 Onaivi, E. S. and Akinshola, B. E. In-vitro and in-vivo action of cannabinoids. IBRO Absts. 1999.

68 Onaivi, E. S., Chaudhuri, G., Abaci, A. A., Parker, M., Manier, D. H., Martin, P. R. and Hubbard, J. R. The influence of gender and ethnicity on the expression of cannabinoid receptors and their gene transcripts. IBRO Absts. 1999.

69 Onaivi, E. S., Hubbard, J. R., Aileru, A and Akinshola, B. E. Differential display of genes regulated by cocaine and cannabinoids. Soc. Neurosc. Absts., 25(2), 585.5, 1999.

70 Onaivi ES, Ishiguro H, Zhang PW, Akinshola BE, Lin Z, Darmani N, Leonard C, Hall FS, Hope B and Uhl GR. Cannabinoid genetics and behavior. Society for Neuroscience 32^nd Annual Meeting, Orlando, FL. November 2-7, 2002.

71 Zhang PW, Ishiguro H, Onaivi ES, Lin Z, Uhl GR. Human cannabinoid receptor 1 (CB1) gene structure, polymorphisms and associations with substance abuse. Society for Neuroscience 32^nd Annual Meeting, Orlando, FL. November 2-7, 2002.

72 Onaivi, ES., Colas, D., Hall, FS., Taylor, RE., Uhl, GR. and Akinshola, BE. Interaction of cannabinoids and vanilloids: A biological basis of why some like it hot and others do not. Sixth IBRO world Congress of Neuroscience Abstracts. #2262, pg 206, 2003.

MANUSCRIPTS IN PREPARATION

· Onaivi ES. The anxiolytic profile of buspirone can be detected in the elevated plus-maze test following a₂-stimulation by dexmedetomidine.

· Onaivi, E. S., Bishop-Robinson, C., Parker, K. A., McClendon, K. and Atkins, D. caffeine alters the performance of three mouse strains in the elevated plus-maze test.

· Chirwa, S. S., Bishop-Robinson, C., Parker, K., Chakrabarti, A., Chaudhuri, G. and Onaivi, E. S., Psychostimulant action and the hippocampus: Pharmacology and Physiological studies.

· Onaivi E. S., Payne S, Brock J. W, Hamdi A, Farooqui S, and C Prasad. The performance of Sprague-Dawley and Hooded rats in the shuttle box avoidance paradigm is dependent on the level of protein in diet.

· Onaivi, E. S. Cannabinoid receptor antagonism induces anxiolysis.

· Zhang PW, Ishiguro H, Onaivi ES, Lin Z and Uhl GR. Human cannabinoid receptor 1 gene, polymorphisms and associations with substance abuse (manuscript completed).

· Chirwa SS, Kawai Y, Reasor J, Onaivi, E. Dopamine DA1 receptor activation modulates GAP-43 gene expression and long-term potentiation in guinea pig hippocampus in vivo. Neurosignals (submitted)

· Onaivi ES, Brandoni C, Akinshola BE, and Uhl, GR. Involvement of an endocannabinoid physiological control system in drug and alcohol administration (manuscript completed).